219 related articles for article (PubMed ID: 5634999)
1. The renal clearance of amino acids in a patient with Wilson's disease during penicillamine treatment.
Bell GE; Slivka DC; Huston JR
J Lab Clin Med; 1968 Jan; 71(1):113-21. PubMed ID: 5634999
[No Abstract] [Full Text] [Related]
2. [Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
Indaco A; Pellegrino L; Campanella G
Acta Neurol Quad (Napoli); 1979; 39():160-4. PubMed ID: 555232
[No Abstract] [Full Text] [Related]
3. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
Walshe JM
Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
[No Abstract] [Full Text] [Related]
4. [Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases].
Lange J
Dtsch Med Wochenschr; 1967 Sep; 92(37):1657-62. PubMed ID: 6054323
[No Abstract] [Full Text] [Related]
5. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
Germinario L; Campanella G; D'Addabbo A
Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
[No Abstract] [Full Text] [Related]
6. [Penicillamine treatment of Wilson's disease].
Falkmer S; Samuelson G; Sjölin S
Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
[No Abstract] [Full Text] [Related]
7. [Experiences with penicillamine in Wilson's disease].
Lössner J; Bachmann H; Eichner B
Psychiatr Neurol Med Psychol Beih; 1975; 20-21():48-53. PubMed ID: 829635
[TBL] [Abstract][Full Text] [Related]
8. [Wilson's disease (hepatolenticular degeneration)].
Ferrer S; Grismali J; Vergara F; Madrid R; Colombo M
Rev Med Chil; 1968 Dec; 96(12):779-88. PubMed ID: 5732518
[No Abstract] [Full Text] [Related]
9. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S
Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326
[No Abstract] [Full Text] [Related]
10. [Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine].
Gregersen G; Frederiksen G
Ugeskr Laeger; 1971 Jul; 133(29):1406-9. PubMed ID: 5569040
[No Abstract] [Full Text] [Related]
11. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
[No Abstract] [Full Text] [Related]
12. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
13. [True hepatic Wilson's disease].
Ciravegna B; Giacchino R; Marazzi MG
Pediatr Med Chir; 1983; 5(1-2):7-10. PubMed ID: 6634446
[TBL] [Abstract][Full Text] [Related]
14. Renal clearances of different amino acids in Wilson's disease before and after treatment with penicillamine.
Schonheyder F; Gregersen G; Hansen HE; Skov PE
Acta Med Scand; 1971 Nov; 190(5):395-9. PubMed ID: 5149266
[No Abstract] [Full Text] [Related]
15. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
Lange J; Brandt G
Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
[No Abstract] [Full Text] [Related]
16. Wilson's disease: modification by L-DOPA.
Gelmers HJ; Troost J; Willemse J
Neuropadiatrie; 1973 Dec; 4(4):453-7. PubMed ID: 4801897
[No Abstract] [Full Text] [Related]
17. [Urine copper determination in Wilson's disease during therapy].
Schnack H
Wien Z Inn Med; 1967; 48(12):469-76. PubMed ID: 5620588
[No Abstract] [Full Text] [Related]
18. The discovery of the therapeutic use of D-penicillamine.
Walshe JM
J Rheumatol Suppl; 1981; 7():3-8. PubMed ID: 7014875
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
[No Abstract] [Full Text] [Related]
20. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
